HomePfizer Inc (PFE) Market Cap

Pfizer Inc (PFE) Market Cap

Explore the company's latest market cap.

Pfizer Market capitalization

As of 06 October 2026, Pfizer market cap was $154.99B.

This places Pfizer among the largest pharmaceutical stocks by market value.

Market cap (market capitalisation) is the total value of a company’s shares on the stock market – calculated by multiplying the number of outstanding shares by its current share price.

How has Pfizer market cap changed recently?

Over the past seven days, Pfizer market cap has increased by +0.12%.

Over the past 12 months, it has increased by +1.01%

The company reached a 12-month high of $156.75B on 7 November 2024. With 5.69B shares outstanding, this equated to a share price of $27.57.

Its 12-month low came on 9 April 2025, when the market cap fell to $118.88B, implying a share price of $20.91 based on 5.69B shares.

Fiscal period-end Pfizer market cap

The table below shows Pfizer's market capitalisation at each fiscal quarter-end, providing a reference point for its valuation aligned with its financial reporting periods. This helps illustrate how the company's market value has evolved across different fiscal quarters.

Date	PFE market cap (USD)	Change (%)
June 2025	$137.53B	-3.74%
March 2025	$142.87B	-4.97%
December 2024	$150.35B	-8.80%
September 2024	$164.84B	+3.97%
June 2024	$158.55B	+1.18%
March 2024	$156.70B	-3.61%
December 2023	$162.56B	-13.20%
October 2023	$187.28B	-9.56%
July 2023	$207.07B	-9.68%
April 2023	$229.26B	N/A

Market capitalisation of similar companies

The table below shows other leading companies in the same sector include Abbvie, Bayer, Roche, and Sanofi.

Name	Market Capitalization
Abbvie	$469.14B
Bayer	$43.42B
Roche	$289.75B
Sanofi	$96.17B

Data is sourced from public company disclosures, including SEC filings and EDGAR. It is provided for informational purposes only and does not constitute investment advice or a recommendation to trade. Figures are believed to be accurate at the stated dates but may change without notice.

Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.